天津昂賽細胞基因工程有限公司根據國家發改委“發改高技〔2004〕275號”文件精神，在國家發改委和天津市人民政府的支持和資助下于2004年8月成立，位于天津濱海新區的細胞產品國家工程研究中心，主要從事細胞治療產品、體內外分離與擴增干細胞、基因工程多肽藥物等的研究開發，旨在加速干細胞工程技術開發和基因工程藥物的科研成果向現實生產力轉化。2008年，公司被列入天津市政府未來五年計劃予以重點支持的濱海新區自主創新高新技術平臺項目。公司內設有碩士、博士點和博士后工作站，擁有，其中博士4人、碩士研究人員5人，本科及以上學歷51人。公司自建立以來，堅持走自主創新之路，采用先進的管理機制，集聚干細胞技術和人才優勢，逐漸形成了技術、人才、經濟良性循環發展模式。
天津昂賽細胞基因工程有限公司歡迎國內外致力于我國干細胞事業，生物產業的有識之士加盟，并歡迎為公司的建設和發展獻技獻策。
Introduction

Tianjin AmCellGene Engineering Co., Ltd. according to the national development and reform commission "hair changed high skill [2004] no." the spirit of the documents, 275 at the national development and reform commission and the people's government of tianjin support and funding in August 2004, is located in tianjin binhai new area of cellular products national engineering research center, is mainly engaged in product, the cell therapy and amplification stem cells, genetic engineering polypeptide drugs to accelerate the research and development of stem cell engineering technology development and gene engineering to the drug research into productive forces. In 2008, the company was listed in the tianjin government future five-year plan to support the binhai new area of independent innovation technology platform project. Company consists of the master, doctoral postdoctoral workstation and have experts, including four people, dr ma researchers 5 people, bachelor degree or above, 51. Company since its inception, adhere to the road of independent innovation, and adoption of advanced management mechanism, stem cell technology and talent advantages, and gradually formed a technology, talent, economic cycle development mode.
Tianjin AmCellGene Engineering Co., Ltd. Welcome to our business, biological industry of stem cells, and welcome the man of insight to join in the construction and development of the company for it.